Lehrke M - Search Results

1

Cardiovascular effects of incretin-based therapies.

Lehrke M, Marx N. Lehrke M, et al. Rev Diabet Stud. 2011 Fall;8(3):382-91. doi: 10.1900/RDS.2011.8.382. Epub 2011 Nov 10. Rev Diabet Stud. 2011. PMID: 22262075 Free PMC article. Review.

2

[Cardiovascular effects of incretin-based therapies].

Lehrke M, Marx N. Lehrke M, et al. Herz. 2012 May;37(3):287-93. doi: 10.1007/s00059-012-3599-8. Herz. 2012. PMID: 22430284 German.

3

New antidiabetic therapies: innovative strategies for an old problem.

Lehrke M, Marx N. Lehrke M, et al. Curr Opin Lipidol. 2012 Dec;23(6):569-75. doi: 10.1097/MOL.0b013e328359b19f. Curr Opin Lipidol. 2012. PMID: 23069986 Review.

4

Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans.

Piotrowski K, Becker M, Zugwurst J, Biller-Friedmann I, Spoettl G, Greif M, Leber AW, Becker A, Laubender RP, Lebherz C, Goeke B, Marx N, Parhofer KG, Lehrke M. Piotrowski K, et al. Among authors: lehrke m. Cardiovasc Diabetol. 2013 Aug 16;12:117. doi: 10.1186/1475-2840-12-117. Cardiovasc Diabetol. 2013. PMID: 23953602 Free PMC article.

5

Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe⁻/⁻ mice.

Burgmaier M, Liberman A, Möllmann J, Kahles F, Reith S, Lebherz C, Marx N, Lehrke M. Burgmaier M, et al. Among authors: lehrke m. Atherosclerosis. 2013 Dec;231(2):427-35. doi: 10.1016/j.atherosclerosis.2013.08.033. Epub 2013 Sep 5. Atherosclerosis. 2013. PMID: 24267262

6

GLP-1 secretion is increased by inflammatory stimuli in an IL-6-dependent manner, leading to hyperinsulinemia and blood glucose lowering.

Kahles F, Meyer C, Möllmann J, Diebold S, Findeisen HM, Lebherz C, Trautwein C, Koch A, Tacke F, Marx N, Lehrke M. Kahles F, et al. Among authors: lehrke m. Diabetes. 2014 Oct;63(10):3221-9. doi: 10.2337/db14-0100. Epub 2014 Jun 19. Diabetes. 2014. PMID: 24947356

7

Safety and Tolerability of Linagliptin in Patients With Type 2 Diabetes: A Comprehensive Pooled Analysis of 22 Placebo-controlled Studies.

Lehrke M, Marx N, Patel S, Seck T, Crowe S, Cheng K, von Eynatten M, Johansen OE. Lehrke M, et al. Clin Ther. 2014 Aug 1;36(8):1130-46. doi: 10.1016/j.clinthera.2014.06.008. Epub 2014 Jul 8. Clin Ther. 2014. PMID: 25015594 Free article.

8

PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.

Lehrke M, Kahles F, Makowska A, Tilstam PV, Diebold S, Marx J, Stöhr R, Hess K, Endorf EB, Bruemmer D, Marx N, Findeisen HM. Lehrke M, et al. J Mol Cell Cardiol. 2015 Apr;81:23-33. doi: 10.1016/j.yjmcc.2015.01.015. Epub 2015 Jan 30. J Mol Cell Cardiol. 2015. PMID: 25640159

9

[IL-6 dependent GLP-1 secretion during acute inflammation].

Kahles F, Meyer C, Möllmann J, Diebold S, Findeisen HM, Lebherz C, Trautwein C, Koch A, Tacke F, Marx N, Lehrke M. Kahles F, et al. Among authors: lehrke m. Med Klin Intensivmed Notfmed. 2015 Sep;110(6):462-4. doi: 10.1007/s00063-015-0059-2. Med Klin Intensivmed Notfmed. 2015. PMID: 26250691 German. No abstract available.

10

High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms.

Schuett KA, Lehrke M, Marx N, Burgmaier M. Schuett KA, et al. Among authors: lehrke m. Front Immunol. 2015 Nov 23;6:591. doi: 10.3389/fimmu.2015.00591. eCollection 2015. Front Immunol. 2015. PMID: 26635805 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters